AU615883B2 - Pharmaceutical composition for use against hypertension and congestive heart failure - Google Patents

Pharmaceutical composition for use against hypertension and congestive heart failure Download PDF

Info

Publication number
AU615883B2
AU615883B2 AU80576/87A AU8057687A AU615883B2 AU 615883 B2 AU615883 B2 AU 615883B2 AU 80576/87 A AU80576/87 A AU 80576/87A AU 8057687 A AU8057687 A AU 8057687A AU 615883 B2 AU615883 B2 AU 615883B2
Authority
AU
Australia
Prior art keywords
alkyl
carbon atoms
hydroxy
independently
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80576/87A
Other languages
English (en)
Other versions
AU8057687A (en
Inventor
Robert Paul Hof
Helene Siegl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU8057687A publication Critical patent/AU8057687A/en
Application granted granted Critical
Publication of AU615883B2 publication Critical patent/AU615883B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU80576/87A 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure Ceased AU615883B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB8626217 1986-11-03
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions
GB8713349 1987-06-08

Publications (2)

Publication Number Publication Date
AU8057687A AU8057687A (en) 1988-05-05
AU615883B2 true AU615883B2 (en) 1991-10-17

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80576/87A Ceased AU615883B2 (en) 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure

Country Status (25)

Country Link
KR (1) KR960005145B1 (de)
AT (1) AT397343B (de)
AU (1) AU615883B2 (de)
BE (1) BE1002063A4 (de)
CA (1) CA1314222C (de)
CH (1) CH677189A5 (de)
DE (1) DE3736505A1 (de)
DK (1) DK574087A (de)
ES (1) ES2010524A6 (de)
FI (1) FI874823A (de)
FR (1) FR2605885B1 (de)
GR (1) GR871680B (de)
HK (1) HK138893A (de)
HU (1) HU199681B (de)
IE (1) IE60496B1 (de)
IL (1) IL84343A (de)
IT (1) IT1212037B (de)
LU (1) LU87034A1 (de)
MY (1) MY102124A (de)
NL (1) NL8702502A (de)
NO (1) NO874539L (de)
NZ (1) NZ222401A (de)
PH (1) PH23249A (de)
PT (1) PT86062B (de)
SE (1) SE8704272L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
GB2198641A (en) * 1986-11-03 1988-06-22 Sandoz Ltd Pharmaceutical cardiac compositions containing calcium antagonists
AU2640488A (en) * 1987-12-14 1989-06-15 E.R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ace inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
GB2198641A (en) * 1986-11-03 1988-06-22 Sandoz Ltd Pharmaceutical cardiac compositions containing calcium antagonists
AU2640488A (en) * 1987-12-14 1989-06-15 E.R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ace inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (de) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
US5266573A (en) Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
DE69435021T2 (de) Kombination eines Angiotensin-II antagonistisch wirkenden Benzimidazols mit einem Diuretikum
US20010006972A1 (en) Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
JPS6197228A (ja) ジヒドロピリジン類とａｃｅ阻害剤との配合物
CA2003289C (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
JP2002537258A5 (de)
JPH0334926A (ja) 抗不安薬
AU615883B2 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
US5021426A (en) Method of traeting malaria with cyproheptadine derivatives
US4859665A (en) Antihypertensive combination products containing a dihydropyridine and a pyridazodiazepine
US5109005A (en) Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
US4871738A (en) Use of 2-pyrimidinyl-1-piperazine derivatives in the treatment of dependence on nicotine
US4157394A (en) Cardio-protective pharmaceutical composition
US4797404A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
CA2119777C (en) An ameliorant for blood lipid metabolism
RO117297B1 (ro) Metoda de tratament a alcoolismului cronic sau a starilor datorate abuzului de alcool
GB2198641A (en) Pharmaceutical cardiac compositions containing calcium antagonists
US4931435A (en) Agent with an antidepressant activity
NL194958C (nl) Farmaceutische eenheidsdosering van benazepril/thiazidediureticum in lage dosering.
US4666922A (en) Method for modulating the immune response
EP0381074A2 (de) Verfahren zur Diäterleichterung unter Verwendung eines ACE-Inhibitors
US3900563A (en) Method of using 3-(2-(4-phenyl-1-piperazinyl)ethyl)-indolines
JPH0676322B2 (ja) アザナフタレン含有医薬組成物
US4847280A (en) Novel treatment
US4988720A (en) Novel treatment of hyperglycaemia

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired